Link Pharma Chem sets Aug 20 date for 41st AGM
Link Pharma Chem Limited convenes its 41st AGM on August 20, 2026, via video conference. Key agenda items include adopting FY26 financials, appointing Y. S. Thakar & Co. as cost auditors, and Vijay Bhatt & Co. as secretarial auditors. Shareholders will also vote on the re-appointment of Satish G. Thakur and Rishikesh Thakur to their respective executive roles for three-year terms.

*this image is generated using AI for illustrative purposes only.
Link Pharma Chem Limited has scheduled its 41st Annual General Meeting (AGM) for Thursday, August 20, 2026, at 11:30 a.m. IST. The meeting will be conducted through Video Conferencing (VC) or Other Audio-Visual Means (OAVM) in compliance with Ministry of Corporate Affairs circulars. This virtual format allows shareholders to participate remotely, ensuring broader accessibility while adhering to regulatory guidelines regarding physical attendance restrictions.
The primary objective of the gathering is to transact ordinary business, including the consideration and adoption of the Audited Financial Statements for the financial year ended March 31, 2026. Additionally, shareholders will vote on the re-appointment of Mr. Satish Thakur as a director, who retires by rotation and offers himself for re-election. The Board of Directors has recommended these actions based on the company’s performance and governance requirements for FY26.
Special business items form a significant portion of the agenda, focusing on key managerial and audit appointments. Shareholders are asked to approve the ratification of remuneration for Cost Auditors M/s. Y. S. Thakar & Co., who have been appointed by the Board to audit cost records for FY27. The proposed remuneration is ₹45,000 per annum plus applicable taxes and reimbursement of actual out-of-pocket expenses incurred during the audit process.
Furthermore, the meeting seeks approval for the appointment of Vijay Bhatt & Co., Practicing Company Secretaries, as Secretarial Auditors for a four-year term from FY27 to FY30. This appointment aligns with Section 204 of the Companies Act, 2013, and Regulation 24A of the SEBI Listing Regulations. The firm’s remuneration will be mutually agreed upon by the Board and the auditors, with provisions for revision based on inflation during the tenure.
The most critical special resolutions involve the re-appointment of senior leadership. Shareholders must pass a special resolution to re-appoint Mr. Satish G. Thakur as Chairman & Whole-time Director for three years, effective June 24, 2026, with a consolidated salary of ₹4.00 Lacs per month. Similarly, Mr. Rishikesh Thakur is up for re-appointment as Managing Director for three years, effective September 24, 2026, at a consolidated salary of ₹3.00 Lacs per month. Both directors have extensive experience in the chemical industry, with Mr. Thakur bringing over 43 years of expertise and Mr. Rishikesh Thakur contributing over 15 years in operations and R&D.
Key Dates and Voting Details
| Event | Date/Period |
|---|---|
| E-Voting Period | August 17–19, 2026 |
| Record Date | August 13, 2026 |
| Book Closure | August 14–20, 2026 |
| AGM Date | August 20, 2026 |
Shareholders holding shares as on the cut-off date of August 13, 2026, are eligible to vote. Remote e-voting begins on Monday, August 17, 2026, at 9:00 a.m. and ends on Wednesday, August 19, 2026, at 5:00 p.m. The Register of Members and Share Transfer Books will remain closed from Friday, August 14, 2026, to Thursday, August 20, 2026, inclusive. Participants can join the VC/OAVM session via InstaMeet, with login facilities opening 30 minutes prior to the scheduled start time.
Leadership and Audit Appointments
| Resolution | Candidate/Firm | Tenure/Details |
|---|---|---|
| Cost Auditor | Y. S. Thakar & Co. | FY27; ₹45,000 p.a. + taxes |
| Secretarial Auditor | Vijay Bhatt & Co. | 4 years (FY27–FY30) |
| Chairman & WTD | Satish G. Thakur | 3 years; ₹4.00 Lacs/month |
| Managing Director | Rishikesh Thakur | 3 years; ₹3.00 Lacs/month |
The Board emphasizes that none of the directors or key managerial personnel have any financial interest in the auditor appointments, except through their shareholdings. For the leadership re-appointments, conflicts are limited to the inter-se relationship between Mr. Satish G. Thakur and Mr. Rishikesh Thakur, who are related, and their respective shareholding interests in the company.
Historical Stock Returns for Link Pharma Chem
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -5.00% | -1.48% | -1.48% | -13.64% | -23.45% | -29.35% |
How might the re-appointment of long-serving leadership impact Link Pharma Chem's strategic direction and innovation pipeline in the competitive chemical sector?
What are the implications of the fixed remuneration structure for the Chairman and Managing Director compared to industry benchmarks for similar roles?
Could the appointment of a new Secretarial Auditor for a four-year term signal upcoming changes in corporate governance practices or compliance strategies?


































